K. Matsuno, general manager of the Medical Device Business Division of Yamaha Motor, commented: “By combining our technologies, we will improve the quality and robustness of
tissue model applications in high-throughput. Together, we can make advanced 3D human disease models suitable for all stages of early drug development.”
MIMETAS and Yamaha Motor will work together to develop innovative applications of the Cell Handler in combination with MIMETAS’ 3D tissue models. The result is an end-to-end solution, providing pharmaceutical researchers with essential tools to expedite their drug discovery endeavours. The integrated solution will allow automated integration of organoids, spheroids, and tumour tissues into vascularized, perfused and immunocompetent tissues, with increased throughput and improved robustness and reproducibility.